NPR

HHS To Help Companies Develop COVID-19 Vaccines

The Department of Health and Human Services outlined support for Moderna and Johnson & Johnson, as the companies work to develop coronavirus vaccines. Beefing up manufacturing capacity is a priority.
A scientist works in a lab at Moderna in Cambridge, Mass., in February. Moderna has developed an experimental coronavirus medicine, but an approved treatment could be more than a year away.

The Department of Health and Human Services outlined how it will support Moderna and Johnson & Johnson as they develop vaccines against the novel coronavirus that's sickened more than 800,000 people worldwide as of Tuesday afternoon.

HHS's Biomedical Advanced Research and Development Authority, that it will help speed up clinical trials for both companies' experimental vaccines, and support Janssen Pharmaceuticals, a unit of Johnson & Johnson, in making up to 300 million doses annually in the U.S..

You’re reading a preview, subscribe to read more.

More from NPR

NPR3 min read
WNBA Teams Will Travel On Chartered Flights For The Next 2 Seasons, The League Says
Before, teams could travel on chartered flights during the postseason and for back-to-back games in the regular season. Many players said the change will make recovery easier and make them feel safer.
NPR2 min read
What's Past Is Present For Ukrainian Composer Valentin Silvestrov
The 86-year-old Kyiv native, living in exile in Berlin, has a new album of symphonic works that explores the idea of reminiscence.
NPR4 min read
Yes, Apple's New IPad Ad Is Ugly And Crushing, But Art Can't Be Flattened
The newest iPad ad depicts instruments, books and art supplies flattened into Apple's thinnest product ever. But anyone who owns and loves art in any form knows: The practicality isn't the point.

Related Books & Audiobooks